Real-World Experience with Pembrolizumab Treatment in Patients with Heavily Treated Recurrent Gynecologic Malignancies.
Min Chul ChoiYong Wha MoonSang Geun JungHyun ParkWon Duk JooSeung Hun SongChan LeeGwangil KimKyoung Ah KimPublished in: Yonsei medical journal (2020)
In real-world practice, pembrolizumab was feasible and effective in heavily treated recurrent gynecologic cancer patients with poor performance status who may not be eligible for enrollment in clinical trials.